Comparing two different local anaesthetic agents for spinal anaesthesia in view of hemodynamic changes

A Comparative study of 0.5% hyperbaric Levobupivacaine and 0.5% hyperbaric Bupivacaine for spinal anaesthesia in elective lower segment casearean sections - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/059159

Enrollment

Registered

2023-10-26

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 1- Obstetrics

Interventions

Intervention1: Intervention agent 0.5% hyperbaric Levobupivacaine: Group 1 will receive 0.5% hyperbaric Levobupivacaine 2ml intrathecally Duration 18months Control Intervention1: Comparator agent 0.5

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients undergoing elective lower segment casearean sections from 18-40years age 2.ASA physical status II

Exclusion criteria

Exclusion criteria: 1.Patients with ASA physical status III,IV 2.Patients having any contraindications to spinal anaesthesia 3.Patients with history of allergy to local anaesthetic

Design outcomes

Primary

Measure	Time frame
To compare various effects of intrathecal 0.5% Hyperbaric Levobupivacaine & 0.5%hyperbaric Bupivacaine in elective lower segment casearean sections 1.Hemodynamic changesTimepoint: At Oth minute immediately & then 3 6 9 15 20 25 30 45 60 75 90	—

Secondary

Measure	Time frame
Sensory & motor blockade characteristicsTimepoint: At 5minutes	—

Countries

India

Contacts

Public ContactDr Ashwini S

Shimoga institute of medical sciences

ashwini.satrasala@gmail.com9980812398

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026